跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71,339 条关于
“irreversible GLP-1 receptor agonist”
全部
71,339
临床试验
43,024
药物
8,933
机构
1,464
资讯
17,918
2个月前
Dx&Vx Advances Global Out-Licensing Talks for First-in-Class Oral Obesity Drug and Cancer Vaccine at BIO 2026
去年
Biolexis Therapeutics Confirms Novel Allosteric Mechanism for Oral GLP-1 Receptor Agonist
11个月前
Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market
去年
MangoRx Launches Oral Tirzepatide (TRIM) for Weight Loss
5个月前
Vanda Pharmaceuticals Initiates Thetis Trial Testing NEREUS for GLP-1 Receptor Agonist-Induced Vomiting
2年前
HUADONG MEDICINE Reports Positive Phase I Results for Oral GLP-1 Receptor Agonist HDM1002
9个月前
Gan & Lee Pharmaceuticals Launches Phase 3 Trial for Once-Monthly GLP-1 Receptor Agonist Bofanglutide
8个月前
Lupin Secures Exclusive Rights to Novel Fortnightly GLP-1 Receptor Agonist Bofanglutide for Indian Market
去年
FDA Clears Corxel's Phase II Trial for Oral GLP-1 Receptor Agonist CX11 in Obesity Treatment
去年
Eccogene Initiates Phase 1b Trial of Novel Oral GLP-1 Receptor Agonist AZD5004/ECC5004 in China
第 1 页，共 1792 页
上一页
下一页
